Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.580
+0.040 (7.39%)
Nov 21, 2024, 4:00 PM EST - Market closed
MTNB Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 10.3 | 4.79 | 6.83 | 21.03 | 12.43 | 22.17 | Upgrade
|
Short-Term Investments | 0.5 | 8.97 | 21.93 | 28.59 | 46.25 | 5.6 | Upgrade
|
Cash & Short-Term Investments | 10.8 | 13.76 | 28.76 | 49.62 | 58.68 | 27.78 | Upgrade
|
Cash Growth | -40.74% | -52.17% | -42.04% | -15.43% | 111.27% | 123.15% | Upgrade
|
Prepaid Expenses | 0.9 | 1.74 | 5.72 | 1.32 | 2.74 | 1.9 | Upgrade
|
Restricted Cash | - | - | - | - | 0.14 | 0.25 | Upgrade
|
Other Current Assets | 0.05 | 0.05 | 0.05 | 0.05 | - | - | Upgrade
|
Total Current Assets | 11.74 | 15.54 | 34.53 | 50.99 | 61.55 | 29.92 | Upgrade
|
Property, Plant & Equipment | 4.28 | 5.01 | 5.73 | 5.78 | 4.86 | 5.63 | Upgrade
|
Goodwill | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 | Upgrade
|
Long-Term Deferred Charges | 3.02 | 3.02 | 3.02 | 3.02 | 3.02 | 3.02 | Upgrade
|
Other Long-Term Assets | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.34 | Upgrade
|
Total Assets | 20.58 | 25.1 | 44.82 | 61.33 | 70.97 | 40.24 | Upgrade
|
Accounts Payable | 0.35 | 0.51 | 0.62 | 0.94 | 0.35 | 0.68 | Upgrade
|
Accrued Expenses | 1.04 | 1.45 | 2.29 | 1.92 | 2.15 | 1.84 | Upgrade
|
Current Portion of Leases | 0.74 | 0.66 | 0.57 | 0.56 | 0.42 | 0.48 | Upgrade
|
Current Unearned Revenue | - | - | 0.72 | 0.03 | 0.07 | 0.1 | Upgrade
|
Other Current Liabilities | - | - | 0.09 | 0.9 | 0.58 | - | Upgrade
|
Total Current Liabilities | 2.12 | 2.62 | 4.29 | 4.35 | 3.57 | 3.1 | Upgrade
|
Long-Term Leases | 2.33 | 2.9 | 3.56 | 4.14 | 3.33 | 3.75 | Upgrade
|
Long-Term Deferred Tax Liabilities | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | Upgrade
|
Total Liabilities | 4.8 | 5.86 | 8.18 | 8.83 | 7.24 | 7.19 | Upgrade
|
Common Stock | 0 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
Additional Paid-In Capital | 207.17 | 195.02 | 190.07 | 184.25 | 167.19 | 113.43 | Upgrade
|
Retained Earnings | -191.39 | -175.57 | -152.63 | -131.63 | -107.51 | -84.38 | Upgrade
|
Comprehensive Income & Other | - | -0.22 | -0.82 | -0.15 | 0.23 | -0 | Upgrade
|
Total Common Equity | 15.78 | 19.25 | 36.64 | 52.49 | 59.93 | 29.07 | Upgrade
|
Shareholders' Equity | 15.78 | 19.25 | 36.64 | 52.49 | 63.73 | 33.05 | Upgrade
|
Total Liabilities & Equity | 20.58 | 25.1 | 44.82 | 61.33 | 70.97 | 40.24 | Upgrade
|
Total Debt | 3.07 | 3.56 | 4.12 | 4.7 | 3.75 | 4.23 | Upgrade
|
Net Cash (Debt) | 7.72 | 10.2 | 24.64 | 44.92 | 54.93 | 23.55 | Upgrade
|
Net Cash Growth | -46.76% | -58.60% | -45.15% | -18.22% | 133.28% | 95.31% | Upgrade
|
Net Cash Per Share | 1.65 | 2.35 | 5.68 | 10.69 | 13.95 | 8.11 | Upgrade
|
Filing Date Shares Outstanding | 5.09 | 4.35 | 4.35 | 4.34 | 4.09 | 3.93 | Upgrade
|
Total Common Shares Outstanding | 5.09 | 4.35 | 4.35 | 4.33 | 4 | 3.26 | Upgrade
|
Working Capital | 9.62 | 12.92 | 30.25 | 46.65 | 57.99 | 26.83 | Upgrade
|
Book Value Per Share | 3.10 | 4.43 | 8.43 | 12.14 | 14.97 | 8.91 | Upgrade
|
Tangible Book Value | 14.44 | 17.91 | 35.3 | 51.16 | 58.6 | 27.73 | Upgrade
|
Tangible Book Value Per Share | 2.84 | 4.12 | 8.12 | 11.83 | 14.64 | 8.50 | Upgrade
|
Machinery | - | 2.46 | 2.31 | 1.64 | 1.44 | 1.44 | Upgrade
|
Leasehold Improvements | - | 1.16 | 1.16 | 0.94 | 0.88 | 0.88 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.